This is a clinical trial from the Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1020. The goal of this clinical trial is to confirm the therapeutic effect of Wedge resection for ground-glass opacity-featured lung cancer with a size less than 2cm and a consolidation-to-tumor ratio between 0.25 to 0.5.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
286
Wedge resection is a surgical procedure that is done to remove a wedge-shaped section of lung tissue, usually for treating lung cancer. A wedge resection is less invasive than some of the other surgical options used to remove lung cancer.
Fudan University Shanghai Cancer Center
Shanghai, China
5-year overall survival
The event is defined as the death due to any causes.
Time frame: 5 years
5-year recurrence-free survival
The event is defined as the tumor recurrence.
Time frame: 5 years
Postoperative lung function (FEV1)
forced expiratory volume in one second (FEV1)
Time frame: 5 years
Postoperative lung function
forced vital capacity (FVC)
Time frame: 5 years
Sites of tumor recurrence and metastasis
Time frame: 5 years
Radical wedge resection (R0 resection) completion rate
Time frame: 5 years
Surgery-related complications
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.